Study to Assess Umbralisib Plus Ublituximab in Participants With Treatment Naïve Follicular Lymphoma
Clinical trial NCT03828448 · TERMINATED
Trial details
- NCT number
- NCT03828448
- Sponsor
- TG Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-10
- Primary completion
- 2022-05-16
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.